TWO-YEAR SUSTAINED EFFICACY OF A NOVEL, POLYMER-FREE SIROLIMUS ELUTING STENT: LATE RESULTS OF THE VESTASYNC II TRIAL

Background Nonpolymeric drug-eluting stents (DES) have arisen as an attractive alternative to minimize local inflammatory reactions and potentially reduce the adverse events observed following the 1st generation of DES with thick, durable polymers.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E212-E212
Main Authors: de Ribamar Costa, Jos&eacute, Abizaid, Alexandre, Costa, Ricardo, Almeida, Breno, Feres, Fausto, Perin, Marco, Tanajura, Luiz Fernando, Sousa, Amanda, Sousa, J Eduardo
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Hydroxyapatite
Internal Medicine
Stents
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2372-a7f7b8ecdda4eeaf981c81eca01adeffbd41daf62a1edbdebba5ee57c59773b3
cites
container_end_page E212
container_issue 13
container_start_page E212
container_title Journal of the American College of Cardiology
container_volume 59
creator de Ribamar Costa, Jos&eacute
Abizaid, Alexandre
Costa, Ricardo
Almeida, Breno
Feres, Fausto
Perin, Marco
Tanajura, Luiz Fernando
Sousa, Amanda
Sousa, J Eduardo
description Background Nonpolymeric drug-eluting stents (DES) have arisen as an attractive alternative to minimize local inflammatory reactions and potentially reduce the adverse events observed following the 1st generation of DES with thick, durable polymers.
doi_str_mv 10.1016/S0735-1097(12)60213-7
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1547361742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0735109712602137</els_id><sourcerecordid>3380414341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2372-a7f7b8ecdda4eeaf981c81eca01adeffbd41daf62a1edbdebba5ee57c59773b3</originalsourceid><addsrcrecordid>eNqFkFFv0zAUhS0EEmXwE5As8QLSAr5JE6c8gKLibJG8BMXuUJ8sx76RMkq7xR3S_j1pi5i0F57uyznfuecQ8hbYR2CQfVKMJ2kEbMHfQ_whYzEkEX9GZpCmeZSkC_6czP5JXpJXIdwwxrIcFjOy1z-aaC2KlqqV0kVVi29UlGW1LJZr2pS0oHVzLeQ5_d7I9ZVoo7IVgqqqbWR1tVJUyJWu6guqtKj1ZyoLLWgr1EpqdbDrS0GvxQRW63pJq4rqtirka_Kit5uAb_7eM6JLoZeXkWwupmQZuTjhcWR5z7scnfd2jmj7RQ4uB3SWgfXY952fg7d9FltA33nsOpsiptxNlXnSJWfk3Ql7O-7u7jHszc3uftxOiQbSOU8y4PN4UqUnlRt3IYzYm9tx-GXHBwPMHPY1x33NYTwDsTnua_jk-3ry4dTg94CjCW7ArUM_jOj2xu-G_xK-PCG4zbAdnN38xAcMj8-aEBt2ghwYEB8JPPkDJT2O5g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547361742</pqid></control><display><type>article</type><title>TWO-YEAR SUSTAINED EFFICACY OF A NOVEL, POLYMER-FREE SIROLIMUS ELUTING STENT: LATE RESULTS OF THE VESTASYNC II TRIAL</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>de Ribamar Costa, Jos&amp;eacute ; Abizaid, Alexandre ; Costa, Ricardo ; Almeida, Breno ; Feres, Fausto ; Perin, Marco ; Tanajura, Luiz Fernando ; Sousa, Amanda ; Sousa, J Eduardo</creator><creatorcontrib>de Ribamar Costa, Jos&amp;eacute ; Abizaid, Alexandre ; Costa, Ricardo ; Almeida, Breno ; Feres, Fausto ; Perin, Marco ; Tanajura, Luiz Fernando ; Sousa, Amanda ; Sousa, J Eduardo</creatorcontrib><description>Background Nonpolymeric drug-eluting stents (DES) have arisen as an attractive alternative to minimize local inflammatory reactions and potentially reduce the adverse events observed following the 1st generation of DES with thick, durable polymers.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(12)60213-7</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Cardiology ; Cardiovascular ; Hydroxyapatite ; Internal Medicine ; Stents</subject><ispartof>Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E212-E212</ispartof><rights>American College of Cardiology Foundation</rights><rights>2012 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 27, 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2372-a7f7b8ecdda4eeaf981c81eca01adeffbd41daf62a1edbdebba5ee57c59773b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>de Ribamar Costa, Jos&amp;eacute</creatorcontrib><creatorcontrib>Abizaid, Alexandre</creatorcontrib><creatorcontrib>Costa, Ricardo</creatorcontrib><creatorcontrib>Almeida, Breno</creatorcontrib><creatorcontrib>Feres, Fausto</creatorcontrib><creatorcontrib>Perin, Marco</creatorcontrib><creatorcontrib>Tanajura, Luiz Fernando</creatorcontrib><creatorcontrib>Sousa, Amanda</creatorcontrib><creatorcontrib>Sousa, J Eduardo</creatorcontrib><title>TWO-YEAR SUSTAINED EFFICACY OF A NOVEL, POLYMER-FREE SIROLIMUS ELUTING STENT: LATE RESULTS OF THE VESTASYNC II TRIAL</title><title>Journal of the American College of Cardiology</title><description>Background Nonpolymeric drug-eluting stents (DES) have arisen as an attractive alternative to minimize local inflammatory reactions and potentially reduce the adverse events observed following the 1st generation of DES with thick, durable polymers.</description><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Hydroxyapatite</subject><subject>Internal Medicine</subject><subject>Stents</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFkFFv0zAUhS0EEmXwE5As8QLSAr5JE6c8gKLibJG8BMXuUJ8sx76RMkq7xR3S_j1pi5i0F57uyznfuecQ8hbYR2CQfVKMJ2kEbMHfQ_whYzEkEX9GZpCmeZSkC_6czP5JXpJXIdwwxrIcFjOy1z-aaC2KlqqV0kVVi29UlGW1LJZr2pS0oHVzLeQ5_d7I9ZVoo7IVgqqqbWR1tVJUyJWu6guqtKj1ZyoLLWgr1EpqdbDrS0GvxQRW63pJq4rqtirka_Kit5uAb_7eM6JLoZeXkWwupmQZuTjhcWR5z7scnfd2jmj7RQ4uB3SWgfXY952fg7d9FltA33nsOpsiptxNlXnSJWfk3Ql7O-7u7jHszc3uftxOiQbSOU8y4PN4UqUnlRt3IYzYm9tx-GXHBwPMHPY1x33NYTwDsTnua_jk-3ry4dTg94CjCW7ArUM_jOj2xu-G_xK-PCG4zbAdnN38xAcMj8-aEBt2ghwYEB8JPPkDJT2O5g</recordid><startdate>20120327</startdate><enddate>20120327</enddate><creator>de Ribamar Costa, Jos&amp;eacute</creator><creator>Abizaid, Alexandre</creator><creator>Costa, Ricardo</creator><creator>Almeida, Breno</creator><creator>Feres, Fausto</creator><creator>Perin, Marco</creator><creator>Tanajura, Luiz Fernando</creator><creator>Sousa, Amanda</creator><creator>Sousa, J Eduardo</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20120327</creationdate><title>TWO-YEAR SUSTAINED EFFICACY OF A NOVEL, POLYMER-FREE SIROLIMUS ELUTING STENT: LATE RESULTS OF THE VESTASYNC II TRIAL</title><author>de Ribamar Costa, Jos&amp;eacute ; Abizaid, Alexandre ; Costa, Ricardo ; Almeida, Breno ; Feres, Fausto ; Perin, Marco ; Tanajura, Luiz Fernando ; Sousa, Amanda ; Sousa, J Eduardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2372-a7f7b8ecdda4eeaf981c81eca01adeffbd41daf62a1edbdebba5ee57c59773b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Hydroxyapatite</topic><topic>Internal Medicine</topic><topic>Stents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Ribamar Costa, Jos&amp;eacute</creatorcontrib><creatorcontrib>Abizaid, Alexandre</creatorcontrib><creatorcontrib>Costa, Ricardo</creatorcontrib><creatorcontrib>Almeida, Breno</creatorcontrib><creatorcontrib>Feres, Fausto</creatorcontrib><creatorcontrib>Perin, Marco</creatorcontrib><creatorcontrib>Tanajura, Luiz Fernando</creatorcontrib><creatorcontrib>Sousa, Amanda</creatorcontrib><creatorcontrib>Sousa, J Eduardo</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Ribamar Costa, Jos&amp;eacute</au><au>Abizaid, Alexandre</au><au>Costa, Ricardo</au><au>Almeida, Breno</au><au>Feres, Fausto</au><au>Perin, Marco</au><au>Tanajura, Luiz Fernando</au><au>Sousa, Amanda</au><au>Sousa, J Eduardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TWO-YEAR SUSTAINED EFFICACY OF A NOVEL, POLYMER-FREE SIROLIMUS ELUTING STENT: LATE RESULTS OF THE VESTASYNC II TRIAL</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2012-03-27</date><risdate>2012</risdate><volume>59</volume><issue>13</issue><spage>E212</spage><epage>E212</epage><pages>E212-E212</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Background Nonpolymeric drug-eluting stents (DES) have arisen as an attractive alternative to minimize local inflammatory reactions and potentially reduce the adverse events observed following the 1st generation of DES with thick, durable polymers.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(12)60213-7</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E212-E212
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_1547361742
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Cardiology
Cardiovascular
Hydroxyapatite
Internal Medicine
Stents
title TWO-YEAR SUSTAINED EFFICACY OF A NOVEL, POLYMER-FREE SIROLIMUS ELUTING STENT: LATE RESULTS OF THE VESTASYNC II TRIAL
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A17%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TWO-YEAR%20SUSTAINED%20EFFICACY%20OF%20A%20NOVEL,%20POLYMER-FREE%20SIROLIMUS%20ELUTING%20STENT:%20LATE%20RESULTS%20OF%20THE%20VESTASYNC%20II%20TRIAL&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=de%20Ribamar%20Costa,%20Jos&eacute&rft.date=2012-03-27&rft.volume=59&rft.issue=13&rft.spage=E212&rft.epage=E212&rft.pages=E212-E212&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(12)60213-7&rft_dat=%3Cproquest_cross%3E3380414341%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2372-a7f7b8ecdda4eeaf981c81eca01adeffbd41daf62a1edbdebba5ee57c59773b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1547361742&rft_id=info:pmid/&rfr_iscdi=true